SOLID PREPARATION

摘要

A solid preparation for oral administration, which suppresses decomposition of the active ingredient more completely and which is superior in preservation stability and free of problems in oral administration, can be obtained by producing a solid preparation containing ( })4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide or a salt thereof as a solid preparation substantially free of light anhydrous silicic acid, and preferably further containing low substituted hydroxypropylcellulose and/or free of film coating. More preferably, the solid preparation is a plain tablet.